tiprankstipranks
Ulta Beauty downgraded, Palo Alto upgraded: Wall Street’s top analyst calls
PremiumThe FlyUlta Beauty downgraded, Palo Alto upgraded: Wall Street’s top analyst calls
2M ago
Vera Therapeutics initiated with an Overweight at Wells Fargo
Premium
The Fly
Vera Therapeutics initiated with an Overweight at Wells Fargo
2M ago
Vera Therapeutics appoints Jason Carter as Chief Legal Officer
Premium
The Fly
Vera Therapeutics appoints Jason Carter as Chief Legal Officer
2M ago
Vera Therapeutics Advances Atacicept with Promising Trial Results
PremiumCompany AnnouncementsVera Therapeutics Advances Atacicept with Promising Trial Results
3M ago
Vera Therapeutics announces $300M offering of Class A common stock
Premium
The Fly
Vera Therapeutics announces $300M offering of Class A common stock
3M ago
Vera Therapeutics files automatic mixed securities shelf
Premium
The Fly
Vera Therapeutics files automatic mixed securities shelf
3M ago
Vera Therapeutics to expand development pipeline for atacicept
PremiumThe FlyVera Therapeutics to expand development pipeline for atacicept
4M ago
Vera Therapeutics to report results from ORIGIN Phase 2b clinical trial
Premium
The Fly
Vera Therapeutics to report results from ORIGIN Phase 2b clinical trial
4M ago
Vera Therapeutics completes enrollment for Phase 3 ORIGIN 3 trial of atacicept
Premium
The Fly
Vera Therapeutics completes enrollment for Phase 3 ORIGIN 3 trial of atacicept
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100